| Literature DB >> 23983700 |
V Zanagnolo1, D Rollo, T Tomaselli, P G Rosenberg, L Bocciolone, F Landoni, G Aletti, M Peiretti, F Sanguineti, A Maggioni.
Abstract
Introduction. This study was designed to confirm the feasibility and safety of robotic-assisted transperitoneal aortic lymphadenectomy as part of staging procedure for gynecologic malignancies. Methods. Chart review of 51 patients who had undergone robotic staging with aortic lymphadenectomy for different gynaecologic malignancies was performed. Results. The primary diagnosis was as follows: 6 cases of endometrial cancer, 31 epithelial ovarian cancer, 9 nonepithelial ovarian cancer, 4 tubal cancer, and 1 cervical cancer. Median BMI was 23 kg/m(2). Except for a single case of aortic lymphadenectomy only, both aortic and pelvic lymphadenectomies were performed at the time of the staging procedure. All the para-aortic lymphadenectomies were carried out to the level of the renal veinl but 6 cases were carried out to the level of the inferior mesenteric artery. Hysterectomy was performed in 24 patiens (47%). There was no conversion to LPT. The median console time was 285 (range 195-402) with a significant difference between patients who underwent hysterectomy and those who did not. The median estimated blood loss was 50 mL (range 20-200). The mean number of removed nodes was 29 ± 9.6. The mean number of pelvic nodes was 15 ± 7.6, whereas the mean number of para-aortic nodes was 14 ± 6.6. Conclusions. Robotic transperitoneal infrarenal aortic lymphadenectomy as part of staging procedure is feasible and can be safely performed. Additional trocars are needed when pelvic surgery is also performed.Entities:
Year: 2013 PMID: 23983700 PMCID: PMC3747409 DOI: 10.1155/2013/931318
Source DB: PubMed Journal: Obstet Gynecol Int ISSN: 1687-9597
Patients characteristics and hysthology.
| Population characteristics | Numbers |
|---|---|
| Age | 41 (range 18–59) |
| BMI | 23 (range 18–33) |
| Tumor: | |
| Endometrial cancer | 6 |
| Tubal cancer | 4 |
| Cervical cancer | 1 |
| Epithelial ovarian cancer: | 31 |
| Clear cell | 9 |
| Endometrioid | 8 |
| Serous | 8 |
| Squamous | 2 |
| Mixed | 1 |
| Mucinous | 1 |
| Indifferentiated | 1 |
| NA | 1 |
| Nonepithelial ovarian cancer | 9 |
| Dysgerminoma | 7 |
| Immature teratoma | 1 |
| Neuroendocrine tumor | 1 |
Figure 1Trocar sites and OR landscape for paraortic lymphadenectomy [4].
Operation and console time.
| Procedure | Total operative time (min) |
| Console time (min) |
|
|---|---|---|---|---|
| Pelvic + LA plus hysterectomy | 301 | 0.02 | 270 | 0.12 |
| Pelvic + LA without hysterectomy | 270 | 240 |
Mean number of lymph nodes in different groups.
| Pelvic lymph nodes mean (sd) | LA lymph nodes mean (sd) | |
|---|---|---|
| Total lymphadenectomies (Pts = 51) | 15 (±7) | 14 (±6) |
| Systematic lymphadenectomies (Pts = 34) | 20 (±5) | 15 (±5.5) |
| Nonsystematic lymphadenectomies (Pts = 31) | 11.3 (±4) (Pts = 28) | 12 (±6) (Pts = 14) |
| Obese pts (Pts = 8) | 17 (±10) | 13 (±7) |
Intraoperative and postoperative complications.
| Complications | No. pts (%) |
|---|---|
| Intraoperative complications | |
| Significant Bleeding (>500 mL) | 2 (3.9) |
| Conversion rate | 0 |
| Postoperative complications | |
| Trasfusion rate | 3 (5.8) |
| Chylous ascites | 7 (13.7) |
| Vaginal leakage | 2 (3.9) |
| Ureteral fistula | 1 (1.9) |
| Femoral nerve injury | 1 (1.9) |
| Legs edema G1-G2 | 4 (7.8) |
| Port-site hernia | 2 (3.9) |
| Lymphocele | 4 (7.8) |
| Lymphatic ascites | 1 (1.9) |
| Total |
|
Literature review.
| Author | OR Time (min) | EBL (mL) | LOS (day) | Para-aortic nodes ( | Conversion (%) | Complication (%) |
|---|---|---|---|---|---|---|
|
Boggess et al. (2008) | 283 | 47 | 1.4 | 6 | 2.9 | 6.4 |
|
Magrina et al. (2011) | 182 | 141 | 1.9 | 8.7 | 2.9 | 12.0 |
|
Holloway and Ahmad (2012) | 186 | 115 | 1.25 | 7.7 | NA | 1.54 |
|
DeNardis et al. (2008) | 177 | 105 | 1.0 | 6.5 | 5.3 | 14.2 |
|
Lambaudie et al. (2012) | 160 | 112 | 2.9 | 14.6 | 2.2 | 5.0 |
|
Backes et al. (2012) | / | 100 | 1 | 8.8 | 6.3 | 7.2 |
Robotic versus laparotomic hysterectomy and staging endometrial cancer.
| Robotic versus Laparotomic |
Boggess et al. (2008) [ |
Elsahwi et al. (2012) [ |
Magrina et al. (2011) [ |
Paley et al. (2011) [ |
|---|---|---|---|---|
| BMI (Kg/m2) | 33 versus 35 | 34.5 versus 33 | 30.7 versus 30.5 | NA |
| OP time (min) | 191 versus 147* | 127 versus 141* | 182 versus 163 | 283 versus 139* |
| EBL (mL) | 75 versus 266* | 119 versus 155* | 141 versus 472* | 47 versus 198* |
| LOS (day) | 1.0 versus 4.4* | 1.5 versus 4* | 1.9 versus 5.6* | 1.4 versus 5.3* |
| Nodes ( | 33 versus 15* | 20 versus 20 | 25 versus 31* | 16 versus 13 |
| Complication (%) | 5.8 versus 29.7* | 10 versus 27* | 12 versus 30* | 6.4 versus 20.6* |
*P < .001 (mean values).
Robotic versus laparoscopic hysterectomy and staging: endometrial cancer.
| Robotic versus LPS |
Bogges et al. (2008) [ |
Magrina et al. (2011) [ |
Seamon et al. (2009) [ |
Bell et al. (2008) [ |
|---|---|---|---|---|
| BMI (Kg/m2) | 33 versus 29 | 30.7 versus 27.3* | 34 versus 29* | 33 versus 32 |
| OP time (min) | 191 versus 213* | 182 versus 189 | 242 versus 287* | 184 versus 171 |
| EBL (mL) | 75 versus 146* | 141 versus 300* | 100 versus 250* | 166 versus 253* |
| LOS (day) | 1.0 versus 1.2 | 1.9 versus 3.4* | 1 versus 2* | 2.0 versus 2.3 |
| Nodes ( | 33 versus 23* | 25 versus 27 | 21 versus 22 | 17 versus 17 |
| Conversion (%) | 2.9 versus 4.9 | 2.9 versus 10.8* | 12 versus 26* | NA |
| Complication (%) | 5.8 versus 13.6* | 12 versus 14 | 13 versus 14 | 7.5 versus 20* |
*P < .001 (mean values).